Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 1030-1036, April 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, M. R.
Right arrow Articles by Jones, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, M. R.
Right arrow Articles by Jones, H. B.

Tumor Incidence and Cellularity in Lungs of Mice Given Various Dose Schedules of Urethan1

Margaret R. White, Alexander Grendon and Hardin B. Jones

Donner Laboratory and Lawrence Radiation Laboratory, University of California, Berkeley, California 94720

In a previous investigation of the effects of single versus fractionated doses of urethan, we found decreases in tumor yield on fractionation regardless of the size or spacing of the fractions. Other investigators, however, reported increases in tumor yield with certain fractionation schedules. It was thought possible that this difference in result was due to age differences in the mice. Repetition of the experiment with a range of ages, as reported here, still showed a decrease in tumor yield as a result of fractionation. An age effect was seen in that older animals had fewer tumors than younger ones when individual doses of 0.5 mg urethan/g body weight (mg/g) were given. This age effect was not apparent when the individual dose was 1.0 mg/g.

Other investigators have reported urethan-induced hyperplasia in the alveolar walls of lung tissue. Since such hyperplasia might indicate the presence of cells in an early stage of tumor development, a study intended to find whether there was a correlation between hyperplasia and tumor yield was undertaken. There was, however, no observable hyperplasia of alveolar cells in the lung. Cellularity per unit volume of lung did change with age. The number of cells correlated inversely with the alveolar space in fresh lung.

Some hypotheses are suggested to explain the differences between results obtained by other investigators and those obtained by us.

1 This investigation was supported in part by Research Grant GM-10525 from the NIH, USPHS, to the Statistical Laboratory, University of California, Berkeley, and in part by the U. S. Atomic Energy Commission.

Received 7/15/69. Accepted 10/ 9/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.